BC Platforms and Microsoft to Provide Expanded Genomic Data Management Solutions in the Cloud

BC Platforms and Microsoft to Provide Expanded Genomic Data Management Solutions in the Cloud

BASEL, Switzerland and HELSINKI, March 2, 2016 /PRNewswire/ --

BC Platforms, a world leader in genomic data management solutions, today announced that it will collaborate with Microsoft to use the Microsoft Azure cloud platform and services to provide integrated genomic data management solutions in healthcare. Microsoft Corp. and BC Platforms will build the first proof of concept case with Helsinki University Hospital in 2016.

"Microsoft is the first cloud provider recognized by the European Union's data protection authorities for the commitment of rigorous EU privacy laws, which is one of the main reasons BC Platforms decided to implement our computing and analytics on Microsoft Azure," Tero Silvola, CEO of BC Platforms commented on the collaboration.

With this collaboration, BC Platforms can bring more new customers on board with the confidence that the solution can be rapidly up-scaled as needed.

"With Microsoft Azure, we don't have to worry about setting up additional infrastructure or whether we can sustain growth with the current capacity in our data centers. Instead, we can seamlessly connect our current infrastructure with cloud," says Chief Architect Timo Kanninen at BC Platforms.

"We are delighted to be providing these genomics solutions on Microsoft Azure, in collaboration with BC Platforms. Together, we can provide a complete platform for the interpretation of complex genomic and clinical data across key international markets," said David Heckerman, distinguished scientist at Microsoft.

IT Director, Mikko Rotonen from University Hospital Helsinki commented: "Microsoft and BC Platforms are committed to the integration of genomic data, alongside clinical data, to provide the best health outcomes for patients. We are pleased to be working with both companies to tackle the major challenges that we currently face in translating this data into clinical benefits."

Notes to editors:

About BC Platforms 
BC Platforms is a world leader in providing powerful genomic data management solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies. Our high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information. BC Platforms' vision is to revolutionize decision making in drug development to bring clinical benefits to patients. Founded in 1997, the Company has a strong scientific heritage underpinned by 18 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors.

We currently provide solutions to over 50 leading international institutions in 18 countries including top-tier academic and hospital research groups, major pharmaceutical and agricultural companies. Our management team consists of industry leaders with over 90 years of combined experience in life sciences, computational biology and industrial technology. BC Platforms has global operations with its headquarters in Basel, Switzerland, research and development located in Helsinki, Finland, and sales and marketing based in London, Boston, and Vancouver. For more information, please visit http://www.bcplatforms.com or follow us on Twitter @BCPlatforms.

Media contacts:

For more information, please contact:
BC Platforms
Tero Silvola, CEO
tel. Image removed.+358-40-590-5733
email: tero.silvola@bcplatforms.com

Katja Stout, Citigate Dewe Rogerson
tel. Image removed.+44(0)20-7282-1066
email: katja.stout@citigatedr.co.uk

SOURCE BC Platforms